Federal grants to Bolder Biotechnology Inc
Bolder Biotechnology Inc in Louisville, Colorado received $2.3 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Allergy and Infectious Diseases Research, with $2.3 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.3 million
- Awards3
- Awarded in FY 2025$0
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $300,000 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $1.0 million |
| FY 2024 | 2 | $1.0 million |
| FY 2025 | 0 | $0 |
Programs that fund Bolder Biotechnology Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $2.3 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation - abstract. Bone marrow is one of the most radiation-sensitive tissues, and patients acutely exposed to total body irradiation (TBI) doses > 2 gy develop severe neutropenia, thro | Allergy and Infectious Diseases Research | May 23, 2023 | $1.7 million |
| Stimulating innate immunity to protect against ebola virus infection - abstract. Filoviruses such as ebola and marburg viruses are category a pathogens (pathogens that provide the highest risk to national security and public health) on niaid's list of emerging infectious diseases due to their ease o | Allergy and Infectious Diseases Research | July 2, 2021 | $300,000 |
| Improving survival from burkholderia pseudomallei and other pathogenic intracellular bacteria - abstract. Burkholderia pseudomallei (BPM) is a facultative intracellular bacterium that is the causative agent of melioidosis. Bpm is a CDC tier 1 select agent, which a biological agent that has been dete | Allergy and Infectious Diseases Research | January 23, 2024 | $295,924 |
Questions people ask
How much federal grant money does Bolder Biotechnology Inc get?
$2.3 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Bolder Biotechnology Inc the most?
The Department of Health and Human Services, with $2.3 million in 3 awards.
What is Bolder Biotechnology Inc's largest federal grant?
$1.7 million under Allergy and Infectious Diseases Research, with its first action in the period on May 23, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Louisville
- Solid Power Operating, Inc
- Amp Robotics Corporation
- Alpen High Performance Products, Inc.
- Atmospheric & Space Technology Research Associates LLC
- Quspin Inc.
- Amidebio, LLC
- Sierra Space Corp
- Town of Superior
Largest federal grant recipients in Colorado · Federal grants in Colorado